• 1
    Barness LA, Opitz JM, Gilbert-Barness E. Obesity: Genetic, molecular, and environmental aspects. Am J Med Genet A 2007;143A:3016-3034.
  • 2
    WHO. Preventing Chronic Diseases: A Vital Investment: WHO Global Report. World Health Organization, Geneva, Switzerland; 2005.
  • 3
    Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP, Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 2005;330:1360.
  • 4
    Gustafson D, Lissner L, Bengtsson C, Bjorkelund C, Skoog I. A 24-year follow-up of body mass index and cerebral atrophy. Neurology 2004;63:1876-1881.
  • 5
    Kivipelto M, Ngandu T, Fratiglioni L, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 2005;62:1556-1560.
  • 6
    Ward MA, Carlsson CM, Trivedi MA, Sager MA, Johnson SC. The effect of body mass index on global brain volume in middle-aged adults: a cross sectional study. BMC Neurol 2005;5:5-23.
  • 7
    Volkow ND, Wang GJ, Telang F, et al. Inverse association between BMI and prefrontal metabolic activity in healthy adults. Obesity 2009;17:60-65.
  • 8
    Gazdzinski S, Kornak J, Weiner MW, Meyerhoff DJ, Nat R. Body mass index and magnetic resonance markers of brain integrity in adults. Ann Neurol 2008;63:652-657.
  • 9
    Gazdzinski S, Millin R, Kaiser LG, et al. BMI and neuronal integrity in healthy, cognitively normal elderly: a proton magnetic resonance spectroscopy study. Obesity 2010;18:743-748.
  • 10
    Gonzales MM, Tarumi T, Eagan D, Tanaka H, Vaghasia M, Haley AP. Indirect effects of elevated Body Mass Index on memory performance through altered cerebral metabolite concentrations. Psychosom Med 2012;74:691-698.
  • 11
    Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993;15:289-298.
  • 12
    Cloak CC, Chang L, Ernst T. Increased frontal white matter diffusion is associated with glial metabolites and psychomotor slowing in HIV. J Neuroimmunol 2004;157:147-152.
  • 13
    Kantarci K, Jack CR, Xu YC, et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study. Neurology 2000;55:210-217.
  • 14
    Summers M, Swanton J, Fernando K, et al. Cognitive impairment in multiple sclerosis can be predicted by imaging early in the disease. J Neurol Neurosurg Psychiatry 2008;79:955-958.
  • 15
    Eagan DE, Gonzales MM, Tarumi T, Tanaka H, Stautberg S, Haley AP. Elevated serum C-reactive protein relates to increased cerebral myo-inositol levels in middle-aged adults. Cardiovasc Psychiatry Neurol 2012;Epub 2012 Feb 22.
  • 16
    Bailey-Downs LC, Tucsek Z, Toth P, et al. Aging exacerbates obesity-induced oxidative stress and inflammation in perivascular adipose tissue in mice: a paracrine mechanism contributing to vascular redox dysregulation and inflammation. J Gerontol A Biol Sci Med Sci 2012;Epub ahead of Print.
  • 17
    Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003;289:76-79.
  • 18
    NIH. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda, MD: National Institutes of Health; 1998.
  • 19
    Knopman D, Boland LL, Mosley T, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001;56:42-48.
  • 20
    Meyer JS, Rauch GM, Crawford K, et al. Risk factors accelerating cerebral degenerative changes, cognitive decline and dementia. Int J Geriatr Psychiatry 1999;14:1050-1061.
  • 21
    García Santos JM, Fuentes LJ, Vidal JB, et al. Posterior paralimbic and frontal metabolite impairments in asymptomatic hypertension with different treatment outcomes. Hypertens Res 2010;33:67-75.
  • 22
    Geissler A, Fründ R, Schölmerich J, Feuerbach S, Zietz B. Alterations of cerebral metabolism in patients with diabetes mellitus studied by proton magnetic resonance spectroscopy. Exp Clin Endocrinol Diabetes 2003;111:421-427.
  • 23
    Haley AP, Gonzales MM, Tarumi T, Miles SC, Goudarzi K, Tanaka H. Elevated cerebral glutamate and myo-inositol levels in cognitively normal middle-aged adults with metabolic syndrome. Metab Brain Dis 2010;25:397-405.
  • 24
    Reiman EM, Chen KW, Alexander GE, et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA 2004;101:284-289.
  • 25
    Haley AP, Gunstad J, Cohen RA, Jerskey BA, Mulligan R, Sweet LH. Neural correlates of visuospatial working memory in healthy young adults at risk for hypertension. Brain Imaging Behav 2008;2:192-199.
  • 26
    Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-679.
  • 27
    Danielsen ER, Ross, B. Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases. New York, NY: Marcel Dekker, Inc.; 1999.
  • 28
    Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173-1182.
  • 29
    Preacher K, Hayes, A. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Copmut 2004;36:717-731.
  • 30
    Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008;40:879-891.
  • 31
    Greenberg RA, Sacks DB. Screening for diabetes: is it warranted?Clin Chim Acta 2002;315:61-69.
  • 32
    Franssen R, Monajemi H, Stroes ESG, Kastelein JJP. Obesity and dyslipidemia. Med Clin North Am 2011;95:893-902.
  • 33
    Farr SA, Yamada KA, Butterfield DA, et al. Obesity and hypertriglyceridemia produce cognitive impairment. Endocrinology 2008;149:2628-2636.
  • 34
    de Frias CA, Bunce D, Wahlin A, et al. Cholesterol and triglycerides moderate the effect of apolipoprotein E on memory functioning in older adults. J Gerontol B Psychol 2007;62:P112-P118.
  • 35
    Perlmuter LC, Nathan DM, Goldfinger SH, Russo PA, Yates J, Larkin M. Triglyceride levels affect cognitive function in noninsulin-dependent diabetics. J Diabet Complications 1988;2:210-213.
  • 36
    van den Kommer TN, Dik MG, Comijs HC, Jonker C, Deeg DJH. The role of lipoproteins and inflammation in cognitive decline: Do they interact? Neurobiol Aging 2012;33:e1-e12.
  • 37
    Toth PP. The “good cholesterol” - high-density lipoprotein. Circulation 2005;111:E89-E91.
  • 38
    Navab M, Ananthramaiah GM, Reddy ST, et al. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res 2004;45:993-1007.
  • 39
    Scanu A, Molnarfi N, Brandt KJ, Gruaz L, Dayer JM, Burger D. Stimulated T cells generate microparticles, which mimic cellular contact activation of human monocytes: differential regulation of pro- and anti-inflammatory cytokine production by high-density lipoproteins. J Leukoc Biol 2008;83:921-927.
  • 40
    Wadham C, Albanese N, Roberts J, et al. High-density lipoproteins neutralize C-reactive protein proinflammatory activity. Circulation 2004;109:2116-2122.
  • 41
    Atzmon G, Gabriely I, Greiner W, Davidson D, Schechter C, Barzilai N. Plasma HDL levels highly correlate with cognitive function in exceptional longevity. J Gerontol A Biol Sci Med Sci 2002;57:M712-M715.
  • 42
    Vaisar T, Pennathur S, Green PS, et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest 2007;117:746-756.
  • 43
    Movva R, Rader DJ. Laboratory assessment of HDL heterogeneity and function. Clin Chem 2008;54:788-800.